Comparative case fatality analysis of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial: Variation by country beyond predictive profile

This publication has 18 references indexed in Scilit:

• Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: Experience gleaned from the international tissue plasminogen activator/streptokinase mortality trial
  Journal of the American College of Cardiology, 1992
• Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction
  The American Journal of Cardiology, 1990
• In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin
  The Lancet, 1990
• Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
  New England Journal of Medicine, 1989
• THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY
  The Lancet, 1988
• Prognosis after myocardial infarction: results of 15 year follow up.
  BMJ, 1984
• Stepwise risk stratification soon after acute myocardial infarction
  The American Journal of Cardiology, 1983
• Comparison of clinical signs and hemodynamic state in the early hours of transmural myocardial infarction
  American Heart Journal, 1982
• A REVIEW OF GOODNESS OF FIT STATISTICS FOR USE IN THE DEVELOPMENT OF LOGISTIC REGRESSION MODELS1
  American Journal of Epidemiology, 1982
• FAT, FIBRINOLYSIS, AND ATHEROSCLEROSIS IN AFRICANS
  The Lancet, 1957